News | 01 February 2013
NEW YORK, NY--(Marketwire - Feb 1, 2013) - A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012. The iShares NASDAQ Biotechnology Index (IBB), the SPDR S&P Biotech ...
Click on the link to read the full article at Marketwire (press release)
(This link will open in a new window)